Research progress in the treatment of postherpetic neuralgia with Chinese and western medicine
WU Zeyu1 FAN Yiyue2 YANG Ying1
1.Department of Pain, Nanchong Central Hospital, Sichuan Province, Nanchong 637000, China;
2.Graduate School, Chengdu University of Traditional Chinese Medicine, Sichuan Province, Chengdu 610000, China
Abstract:Postherpetic neuralgia is one of the most common complications of herpes zoster and often presents as moderate to severe pain, long-term pain can induce other organ lesions, bring great physical and psychological harm to patients. At present, there are various therapeutic methods for postherpetic neuralgia, and drug therapy is still one of the main therapeutic methods. Western medicine mainly includes calcium channel modulators, antidepressants, non-steroidal anti-inflammatory drugs, topical patches, opioids, and other types of drugs; traditional Chinese medicine believes that the occurrence of postherpetic neuralgia is caused by the dysfunction of viscera, and the treatment should start from harmonizing qi and blood and restoring the function of liver and spleen, the treatment aims to relieve pain, improve sleep, and improve quality of life. This paper summarizes the domestic and foreign literature on the treatment of postherpetic neuralgia and introduces the current situation and progress of Chinese and western medicine in the treatment of postherpetic neuralgia.
吴泽宇1 凡艺月2 杨颖1. 中西药治疗带状疱疹后神经痛的研究进展[J]. 中国医药导报, 2023, 20(10): 59-62.
WU Zeyu1 FAN Yiyue2 YANG Ying1. Research progress in the treatment of postherpetic neuralgia with Chinese and western medicine. 中国医药导报, 2023, 20(10): 59-62.
[1] 带状疱疹后神经痛诊疗共识编写专家组.带状疱疹后神经痛诊疗中国专家共识[J].中国疼痛医学杂志,2016,3(22):161-167.
[2] 陈杨,蒲勋,肖智,等.带状疱疹及带状疱疹后神经痛病人受累神经分布特点[J].中国疼痛医学杂志,2022,28(4):295-298.
[3] Van Hecke O,Austin SK,Khan RA,et al. Neuropathic pain in the general population:a systematic review of epidemiological studies [J]. Pain,2014,155(4):654-662.
[4] Cristiano A,Cecilia T,Chiara P,et al. Incidence of herpes zoster and post-herpetic neuralgia in Italy:Results from a 3-years population-based study [J]. Hum Vaccin Immunother,2017,13(2):399-404.
[5] 黄佳彬,肖礼祖.带状疱疹相关性神经痛的微创介入治疗进展[J].中国疼痛医学杂志,2018,24(11):806-812.
[6] Rai A,Siddique M. Pregabalin and gabapentin for pain [J]. BMJ,2020,369: m1315.
[7] Lin CS,Lin YC,Lao HC,et al. Interventional Treatments for Postherpetic Neuralgia:A Systematic Review [J]. Pain physician,2019,22(3):209-228.
[8] Bruce P,Pan X,Li X,et al. Comparison of the efficacy and safety of pregabalin for postherpetic neuralgia in Chinese and international patients [J]. J Pain Res,2018,11:1699-1708.
[9] Bonnet U,Scherbaum N. How addictive are gabapentin and pregabalin? A systematic review [J]. Eur Neuropsychopharmacol,2017,27(12):1185-1215.
[10] Urits I,Peck J,Orhurhu MS,et al. Off-label Antidepressant Use for Treatment and Management of Chronic Pain:Evolving Understanding and Comprehensive Review [J]. Curr Pain Headache Rep,2019,23(9):66.
[11] Moisset X,Bouhassira D,Attal N. French guidelines for neuropathic pain:An update and commentary [J]. Rev Neurol,2021,177(7):834-837.
[12] Butler S,Eek D,Ring L,et al. The utility/futility of medications for neuropathic pain-an observational study [J]. Scand J Pain,2019,19(2):327-335.
[13] Nayak MK,Kapadia JD,Desai CK,et al. An Evaluation of Efficacy and Safety of Commonly Prescribed Drugs and Effect of These Drugs on Quality of Sleep in Patients Suffering From Zoster-Associated Pain [J]. J Clin Pharmacol,2018, 58(11):1406-1417.
[14] Blair HA. Capsaicin 8% Dermal Patch:A Review in Peripheral Neuropathic Pain [J]. Drugs,2018,78(14):1489-1500.
[15] Liu X,Wei L,Zeng Q,et al. The Treatment of Topical Drugs for Postherpetic Neuralgia:A Network Meta-Analysis [J]. Pain physician,2020,23(6):541-551.
[16] Subedi M,Bajaj S,Kumar MS,et al. An overview of Tramadol and its usage in pain management and future perspective [J]. Biomed Pharmacother,2018,111:443-451.
[17] 蔡军,胡秀华,章勇,等.硬膜外持续输注曲马多治疗带状疱疹后神经痛的临床研究[J].中国疼痛医学杂志,2018,3(24):221-224.
[18] 易小清,崔小娇,陈祝君,等.2021年欧洲《阿片类药物治疗慢性非癌性疼痛的临床实践建议》解读[J].医药导报,2021,9(40):1176-1182.
[19] Jeffrey G,Fudin J,Wang E,et al. Treatment Patterns and Medication Use in Patients with Postherpetic Neuralgia [J]. J Manag Care Spec Pharm,2019,12(25):1387-1396.
[20] Song D,He A,Xu R,et al. Efficacy of Pain Relief in Different Postherpetic Neuralgia Therapies:A Network Meta- Analysis [J]. Pain Physician,2018,21(1):19-32.
[21] 刘尧,陈立平,孙凯,等.维生素C治疗带状疱疹痛的研究进展[J].中国疼痛医学杂志,2018,3(24):161-165.
[22] 孟超,张冰,于俊敏,等.普瑞巴林联合替扎尼定治疗带状疱疹后神经痛患者的疗效和安全性[J].中华疼痛学杂志,2021,17(2):186-190.
[23] 程浩,陆伟萍,高献忠,等.氯胺酮和硫酸镁治疗带状疱疹后神经痛的临床疗效比较[J].实用医学杂志,2018, 34(19):3320-3321,3324.
[24] 黄立荣,郭佳妮,吕亚楠,等.肌筋膜内注射富含血小板血浆治疗带状疱疹后神经痛疗效观察[J].中国疼痛医学杂志,2021,27(8):631-634.
[25] 李华亮,潘平雷,陈佳慧,等.A型肉毒毒素治疗三叉神经痛和带状疱疹后神经痛的临床疗效[J].中国临床医学,2020,27(5):834-836.
[26] 王虹桥,薛朝霞.干扰素α用于椎旁神经阻滞治疗带状疱疹后神经痛的临床疗效[J].中国疼痛医学杂志,2020,26(3):191-195.
[27] 王明霞,张金源,廖丽君,等.胸椎旁连续输注亚甲蓝阻滞液治疗胸段带状疱疹后神经痛的疗效观察[J].中国疼痛医学杂志,2021,27(8):591-595.
[28] 汪洋,马民玉.超声引导下竖脊肌平面阻滞联合阿霉素椎间孔注射治疗胸段带状疱疹后神经痛的研究[J].中国实用医刊,2021,48(15):24-27.
[29] 王小璐,郭蕾蕾,刘明,等.带状疱疹后遗神经痛验案[J].中国民间疗法,2021,29(16):104-106.
[30] 张弘,倪海洋.边天羽治疗带状疱疹后神经痛临床经验[J].湖南中医杂志,2018,7(34):57,96.
[31] 陈万辉,梁艳,李春花,等.电针联合柴胡疏肝散治疗胁肋部带状疱疹后遗神经痛临床观察[J].中国中医药现代远程教育,2022,20(2):109-110.
[32] 李健,张乐乐,周玲玲,等.耳穴压丸结合益气养阴方治疗老年带状疱疹后遗神经痛的临床观察[J].现代诊断与治疗,2020,31(13):2026-2028.
[33] 王晓丽,蒋敏之,尤春娟,等.穴位注射联合复元活血汤治疗带状疱疹后遗神经痛60例[J].宁夏医学杂志,2022, 44(5):468-470.
[34] 白雪,陈佳利,陈凡,等.血府逐瘀汤联合刺络放血治疗气滞血瘀型带状疱疹后遗神经痛的临床观察[J].中医药学报,2022,50(7):97-100.
[35] 方伟,申晓琳,张文西.活血化瘀方外敷联合毫火针刺治疗带状疱疹后遗神经痛临床观察[J].实用中医药杂志,2022,38(9):1619-1621.
[36] 杨惠.中医治疗带状疱疹后遗神经痛的临床研究概况[J].中医临床研究,2019,11(27):65-66,148.
[37] 庞博.基于文献数据挖掘的带状疱疹后神经痛用药规律及机制研究[D].广州:广州中医药大学,2021.
[38] 李艳凤,刘雅舒,李艳生,等.柴胡的化学成分与药理作用研究进展[J].西北药学杂志,2022,37(5):186-192.
[39] 马艳春,吴文轩,胡建辉,等.当归的化学成分及药理作用研究进展[J].中医药学报,2022,50(1):111-114.
[40] 张燕丽,田园,付起凤,等.白芍的化学成分和药理作用研究进展[J].中医药学报,2021,49(2):104-109.